Back to results
US 2022/0031629 A1Published application
Ophthalmic compositions for removing meibum or inhibiting meibum buildup
AssigneeAltaire Pharmaceuticals, Inc.
InventorAssad Sawaya
Life of this patent
Estimating the term…
Abstract
Microemulsion formulations containing polyoxyethylene castor oil derivatives (such as polyoxyl 35 castor oil) contain nanoparticle micelles and are capable of dissolving/absorbing meibum materials. By removing obstructive meibum materials that may be positioned in the orifice of meibomian gland channels, the present formulations provide a non-irritating treatment for meibomian gland dysfunction (MGD).
Claims9
An eye treatment formulation comprising;
- nanoparticles formed by at least one polyoxyethylene castor oil derivative, the nanoparticles being present in an amount sufficient to absorb meibum material, and
- wherein the formulation exhibits a clear appearance.
A method comprising:
- administering an eye treatment formulation to a patient experiencing a dry eye condition resulting from meibomian gland dysfunction, the eye treatment formulation including nanoparticles formed by at least one polyoxyethylene castor oil derivative, the nanoparticles being present in an amount sufficient to absorb meibum material, and wherein the eye treatment formulation exhibiting a clear appearance.
Dependencies are inferred from the claim text.